1. Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients. (19th July 2015) Authors: Ruscitti, P; Cipriani, P; Di Benedetto, P; Liakouli, V; Berardicurti, O; Carubbi, F; Ciccia, F; Alvaro, S; Triolo, G; Giacomelli, R Journal: Clinical and experimental immunology Issue: Volume 182:Number 1(2015:Oct.) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PS-101 Risk management of HBV reactivation in haematological patients treated with rituximab. (24th March 2015) Authors: Tristancho, A; Fobelo, MJ; Artacho, S; Jimenez, CJ; Alvaro, S; Manzano, M; Gomez, E; Guzman, MI; Haro, C Journal: European journal of hospital pharmacy Issue: Volume 22(2015)Supplement 1 Page Start: A176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗